title: Antitumour and immune-adjuvant activities of protein-tyrosine kinase inhibitors.
authors.affiliation: Martin-Luther-Universitaet Halle-Wittenberg, Institute of Medical Immunology, 06112 Halle (Saale), Germany. Barbara.Seliger@medizin.uni-halle.de <Barbara.Seliger@medizin.uni-halle.de>
authors.forename: Barbara
authors.initials: B
authors.lastname: Seliger
authors.forename: Chiara
authors.initials: C
authors.lastname: Massa
authors.forename: Brian
authors.initials: B
authors.lastname: Rini
authors.forename: Jennifer
authors.initials: J
authors.lastname: Ko
authors.forename: Jim
authors.initials: J
authors.lastname: Finke
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003713:Dendritic Cells / Q000187:drug effects; D006801:Humans; D007167:Immunotherapy; D051379:Mice; D009369:Neoplasms / Q000201:enzymology / Q000276:immunology / Q000628:therapy*; D009389:Neovascularization, Pathologic / Q000188:drug therapy / Q000276:immunology; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects / Q000276:immunology
chemical_list: D000276:Adjuvants, Immunologic; D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors